|
RSRC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59300000000173E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.378100E-03 |
| Normal-vs-Stage2 |
1.582330E-02 |
| Normal-vs-Stage3 |
2.78909999984478E-07 |
| Normal-vs-Stage4 |
1.9823000000363E-06 |
| Stage1-vs-Stage2 |
9.329200E-01 |
| Stage1-vs-Stage3 |
8.019000E-03 |
| Stage1-vs-Stage4 |
2.380000E-02 |
| Stage2-vs-Stage3 |
7.632300E-02 |
| Stage2-vs-Stage4 |
1.567440E-01 |
| Stage3-vs-Stage4 |
7.754600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.01869999996818E-06 |
| Normal-vs-AfricanAmerican |
1.532420E-01 |
| Normal-vs-Asian |
8.771800E-01 |
| Caucasian-vs-AfricanAmerican |
8.088400E-02 |
| Caucasian-vs-Asian |
7.807800E-02 |
| AfricanAmerican-vs-Asian |
4.614600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90290000001703E-06 |
| Normal-vs-Female |
4.440900E-03 |
| Male-vs-Female |
2.241800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.639300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.564410E-03 |
| Normal-vs-Age(61-80Yrs) |
2.58949999998315E-06 |
| Normal-vs-Age(81-100Yrs) |
2.782000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.015200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.001800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.042800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.434400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.502000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.754000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.414200E-01 |
| Normal-vs-Grade 2 |
8.762200E-03 |
| Normal-vs-Grade 3 |
5.88080000252234E-08 |
| Normal-vs-Grade 4 |
4.96119999970901E-07 |
| Grade 1-vs-Grade 2 |
8.737500E-03 |
| Grade 1-vs-Grade 3 |
3.59119999999713E-05 |
| Grade 1-vs-Grade 4 |
3.5352000000044E-05 |
| Grade 2-vs-Grade 3 |
7.385700E-04 |
| Grade 2-vs-Grade 4 |
3.036600E-03 |
| Grade 3-vs-Grade 4 |
5.260200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.443800E-02 |
| Normal-vs-ccB subtype |
1.56680000085174E-08 |
| ccA subtype-vs-ccB subtype |
1.73419999999203E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.15620000000505E-05 |
| Normal-vs-N1 |
1.715620E-03 |
| N0-vs-N1 |
3.160000E-01 |
|
|
